0000899243-21-014399.txt : 20210401 0000899243-21-014399.hdr.sgml : 20210401 20210401184329 ACCESSION NUMBER: 0000899243-21-014399 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210401 DATE AS OF CHANGE: 20210401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 21799880 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-03-16 2021-03-18 0 0001720580 Adicet Bio, Inc. ACET 0001340875 Schor Chen C/O ADICET BIO, INC. 500 BOYLSTON STREET, 13TH FLOOR BOSTON MA 02116 1 1 0 0 President and CEO Common Stock 2021-03-16 4 S 0 6474 15.07 D 155218 I See footnote Common Stock 2021-03-16 4 S 0 5395 15.66 D 129318 I See footnote Common Stock 2021-03-16 4 S 0 2508 15.07 D 152710 I See footnote Common Stock 2021-03-16 4 S 0 2089 15.66 D 127229 I See footnote Common Stock 2021-01-22 5 G 0 E 26070 D 0 D Common Stock 2021-01-22 5 G 0 E 22985 D 0 I See footnote Common Stock 2021-01-22 5 G 0 E 23570 D 0 I See footnote Common Stock 2021-01-25 5 G 0 E 19286 D 0 I See footnote Common Stock 2021-01-25 5 G 0 E 27014 D 0 I See footnote The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive. Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee. Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee. Represents 26,070 shares transferred by gift by the Reporting Person to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4. Represents 22,985 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4. Represents 23,570 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4. Represents 19,286 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person's spouse is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4. Represents 27,014 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4. /s/ Nick Harvey, Attorney-in-Fact 2021-04-01